UK markets closed
NIKKEI 225
39,631.06 +47.98 (+0.12%) HANG SENG
17,718.61 +2.11 (+0.01%) CRUDE OIL
83.39 +0.01 (+0.01%) GOLD FUTURES
2,341.20 +2.30 (+0.10%) DOW
39,169.52 +50.66 (+0.13%) Bitcoin GBP
49,694.33 +91.41 (+0.18%)
ARQT Jul 2024 7.500 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 01:47PM EDT. Market open.
Loading interactive chart…
- Zacks
FDA Expands AbbVie's (ABBV) Epkinly Label in Follicular Lymphoma
Following the label expansion, AbbVie's (ABBV) Epkinly is the first bispecific antibody approved to treat relapsed/refractory (R/R) follicular lymphoma and R/R diffuse large B-cell lymphoma.
- Zacks
AstraZeneca's (AZN) Imfinzi Meets Study Goal in Bladder Cancer
Data from a late-stage study shows that treatment with AstraZeneca's (AZN) Imfinzi plus chemotherapy before and after bladder removal surgery improves survival in patients.
- Zacks
FDA Expands argenx's (ARGX) Vyvgart Label to Treat Rare Disorder
Per argenx (ARGX), the label expansion to Vyvgart Hytrulo makes it the first FDA-approved medication with a novel mechanism of action to treat chronic inflammatory demyelinating polyneuropathy.
© 2024 Yahoo. All rights reserved.